ACRO Launching New Video Series With Health Coalition Leaders
The Association of Clinical Research Organizations is introducing a new series of videos featuring the leaders of prominent healthcare interest groups.
The first two videos feature Ladd Wiley, Executive Director of the Alliance for a Stronger FDA, and Michael Reilly, Executive Director of the Alliance for Safe Biologic Medicines.
“ACRO participates in several alliances and coalitions to help amplify our message about the importance of clinical research,” said John Lewis, Vice President of Public Affairs. “We thank Ladd and Michael for helping us kick-off this series by discussing the important topics of adequate funding for the FDA and regulatory matters surrounding biosimilars. We plan several additional videos covering issues such as incentives for medical research, regenerative medicine, comparative effectiveness research and the business environment for life sciences in India.”
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
